When GLP-1 receptor agonists like semaglutide and tirzepatide first became popular, the conversation centered almost entirely on weight loss. But as research has accumulated over the past few years, a remarkable story has emerged about GLP-1 and heart health: these medications appear to offer direct, significant cardiovascular benefits that go far beyond what the scale shows.
If you're taking a GLP-1 medication — or considering one — understanding its effects on your cardiovascular system is one of the most important things you can do for your long-term health.
